Mark Lewallyn is a Partner based in New York having joined Centerview in 2016 as a founding member of its market leading healthcare services and technology practice. Over the course of his career, he has advised on more than 50 transactions with aggregate value exceeding $300 billion. His experience includes sell-side and buy-side M&A, spin-offs, divestitures, special committee assignments, shareholder activism defense, and restructurings, and general strategic advisory.
Representative transaction experience includes:
Payors and Value Based Care
- Express Scripts on its $67 billion sale to Cigna
- Oak Street Health on its $11 billion sale to CVS Health
- Cigna on its $3.7 billion sale of its Medicare Businesses and CareAllies to HCSC
- Landmark Health on its $3.3 billion sale to Optum
- CareBridge on its sale to Elevance Health
- HealthSun on its $2.1 billion sale to Elevance Health
- Anthem on its $1.5 billion acquisition of America’s 1st Choice
- Humana on its $725mm acquisition of Enclara Pharmacy
- InnovAge on its sale to Apax Partners
- Molina Healthcare on its terminated acquisition of NextLevel Health
Pharmacy and Supply Chain
- Blackstone, Carlyle, and H&F on their $34 billion acquisition of Medline
- Walgreens in its $24.1 billion sale to Sycamore Partners
- PANTHERx in its sale to Warburg Pincus
- Comprehensive Pharmacy Solutions on its $2.8 billion sale to Optum
- Shields Health Solutions on its $2.5 billion sale to Walgreens
- Genoa Healthcare on its $2.5 billion sale to Optum
- CarepathRx Health System Solutions on its sale to Cigna
- Shields Health Solutions on its sale to Welsh Carson and Walgreens
- Pharmscript on its sale to Optum
- ExactCare on its $570mm acquisition of Tabula Rasa
Providers and Physician Services
- Cardinal Health on its $3.9 billion acquisition of GI Alliance
- Solaris Health in its $2.4 billion sale to Cardinal Health
- BioPlus on its sale to Elevance Health
- OneOncology on its $2.1 billion sale to Cencora and TPG
- Action Behavior Centers in its equity recapitalization
- Physicians Endoscopy in its sale to UnitedHealth
- EyeCare Partners on its refinancing transactions
- OneOncology on its acquisition of United Urology
- Rural Medical Group on its acquisition of Steward Medical Group
- TA Associates on its acquisition of IMA Medical Group
Pharma Services
- ICON on its $12 billion acquisition of PRA Health
- PPD on its $9.1 billion recap with Hellman & Friedman and Carlyle
- Syneos on its $7.1 billion sale to Elliott, Patient Square and Veritas
- INC Research on its $7 billion merger of equals with inVentiv Health
- inVentiv Health on its $3.7 billion sale to Advent
- Linden Capital Partners in its $2.5 billion acquisition of Klick Health
- PharmaCord on its $1.5 billion sale to Permira
- Cencora on its divestiture of its Lash Patient Services business
- ICON on its merger of its Symphony RWD business with HealthVerity
- Kohlberg on its acquisition of Worldwide Clinical Trials
- UBC, a subsidiary of Express Scripts, on its sale to Avista Capital
Healthcare Technology
- MultiPlan on its $11 billion combination with Churchill Capital
- MedRisk on its sale to CVC Capital
- TransUnion RCM, a subsidiary of TransUnion, on its $1.7 billion sale to nThrive
- Fresenius Medical in Humacyte’s $1.1 billion merger with Alpha Health
- Francisco Partners in investments in multiple new HCIT platforms
- Kohlberg on its acquisition of Trinity Life Sciences
- Wellframe on its sale to Healthedge Software
- EQT on its acquisition of Certara
Before joining Centerview, Mr. Lewallyn worked in the Global Healthcare Group at Credit Suisse. Prior to pursuing a career in finance, he worked as an M&A and Capital Markets attorney in the New York office of Gibson, Dunn, & Crutcher.
He received his J.D. from the University of Virginia School of Law and his B.S. from Samford University where he was a four-year letterman on the Division 1 baseball team. He lives in Connecticut with his wife and two young children.